Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Viral (RSV) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02558413
What this trial is testing

Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

Who this might be right for
PharmacokineticsHealthy Volunteers
Biota Pharmaceuticals, Inc. 60
Large-scale testing (Phase 3)Study completedNCT05127434
What this trial is testing

Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 36,814
Early research (Phase 1)Looking for participantsNCT07764237
What this trial is testing

Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)Human Metapneuomovirus (hMPV)
ModernaTX, Inc. 375
Not applicableUnknownNCT05946538
What this trial is testing

Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

Who this might be right for
Respiratory Viral Infection
AusDiagnostics Pty Ltd. 1,000
Large-scale testing (Phase 3)Study completedNCT04908683
What this trial is testing

An Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial VirusesLower Respiratory Tract Disease
Janssen Vaccines & Prevention B.V. 25,236
Not applicableStudy completedNCT00125450
What this trial is testing

Evaluation of Chest Physiotherapy for Acute Bronchiolitis in Toddlers (BRONKINOU)

Who this might be right for
Viral Bronchiolitis
Assistance Publique - Hôpitaux de Paris 500
Not applicableActive Not RecruitingNCT06640387
What this trial is testing

CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools

Who this might be right for
SARS CoV 2 InfectionRSV InfectionInfluenza+2 more
The Hospital for Sick Children 500
Testing effectiveness (Phase 2)Study completedNCT02654171
What this trial is testing

Viral Inhibition in Children for Treatment of RSV

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Shanghai Ark Biopharmaceutical Co., Ltd. 72
Not applicableStudy completedNCT05727202
What this trial is testing

Project STARFISH - PRJ0002679

Who this might be right for
SARS-CoV-2 InfectionInfluenza AInfluenza Type B+1 more
Thermo Fisher Scientific, Inc 1,909
Early research (Phase 1)UnknownNCT04798001
What this trial is testing

Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

Who this might be right for
Covid19
Meissa Vaccines, Inc. 130
Post-approval studies (Phase 4)Study completedNCT02571517
What this trial is testing

Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis

Who this might be right for
Bronchiolitis, Viral
Fundació Sant Joan de Déu 94
Early research (Phase 1)Study completedNCT05585632
What this trial is testing

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Who this might be right for
SARS-CoV-2InfluenzaRSV
ModernaTX, Inc. 392
Testing effectiveness (Phase 2)Ended earlyNCT06999603
What this trial is testing

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

Who this might be right for
Viral Pneumonia
Synairgen Research Ltd. 11
Not applicableNot Yet RecruitingNCT07417657
What this trial is testing

Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants

Who this might be right for
Respiratory Syncytial Virus InfectionBronchiolitisViral Lower Respiratory Tract Infection (LRTI)
Phuc Huu Phan 250
Not applicableEnrolling By InvitationNCT06401720
What this trial is testing

Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection

Who this might be right for
Influenza A InfectionInfluenza B Virus InfectionSARS CoV 2 Infection+1 more
Karolinska Institutet 800
Testing effectiveness (Phase 2)Study completedNCT02718937
What this trial is testing

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Biota Pharma Europe Limited 60
Not applicableStudy completedNCT01349543
What this trial is testing

The Development of a Human Model of Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Viral Infections
Imperial College London 58
Not applicableStudy completedNCT02622009
What this trial is testing

Viral Infections in BAL and Bronchial Biopsies of Stable COPD Patients

Who this might be right for
HRV and RSV Presence in the Lungs of Stable COPD Patients.
University of Athens 53
Not applicableUnknownNCT06392451
What this trial is testing

LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Who this might be right for
Influenza AInfluenza Type BCoronavirus Disease 2019+8 more
DiaSorin Molecular LLC 1,000
Testing effectiveness (Phase 2)Study completedNCT03636906
What this trial is testing

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 201
Next Page